arrow
H

Hin Hin Ko

St Paul's Hospital
H指数:17
被引数:1,305

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Seladelpar for alkaline phosphatase normalization in primary biliary cholangitis: The IDEAL phase III randomized controlled trial

塞拉德尔帕用于原发性胆汁性胆管炎碱性磷酸酶正常化的研究:IDEAL III期随机对照试验

2026-11-080
OA
Ultrasensitive detection of HBsAg and HBV genome analysis in a prospective cohort with chronic hepatitis B after HBV surface antigen loss

慢性乙型肝炎患者队列在HBV表面抗原消失后,对HBsAg的超灵敏检测和HBV基因组的分析

2025-12-010
PRE
Impact of COVID-19 Pandemic on Testing for Hepatitis B in British Columbia, Canada: An Interrupted Time Series Analysis

COVID-19大流行对加拿大不列颠哥伦比亚省乙型肝炎检测的影响:一项中断时间序列分析

2025-12-010
PRE
Recommendations for the diagnosis and management of eosinophilic esophagitis in adults and children in Canada: a Delphi consensus project

加拿大成人及儿童嗜酸性粒细胞性食管炎诊断与管理的建议:一项德尔菲共识项目

2025-11-090
OAAI
Recommendations for the diagnosis and management of eosinophilic esophagitis in adults and children in Canada: a Delphi consensus project

加拿大成人及儿童嗜酸性粒细胞性食管炎的诊断与管理建议:一项德尔菲共识项目

2025-11-010
PRE
Results From Dose Escalation Cohorts 1-6 of RESOLVE, an Ongoing Phase 1b/2a Study of EP-104GI (Long-Acting Fluticasone Propionate Injectable Suspension) for Eosinophilic Esophagitis

RESOLVE研究剂量递增队列1-6的结果,该研究是一项针对EP-104GI(长效丙酸氟替卡松注射混悬液)治疗嗜酸性食管炎的持续进行的1b/2a期研究

2025-10-010
PRE
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial

Levy, C.; Abouda, G.F.; Bilir, B.M.; Bonder, A.; Bowlus, C.L.; Campos-Varela, I.; Cazzagon, N.; Chandok, N.; Cheent, K.; Cortez-Pinto, H.; 等. Elafibranor在原发性硬化性胆管炎中的安全性与有效性:ELMWOOD II期随机对照试验. J. Hepatol. 2025. [Google Scholar] [CrossRef] [PubMed]

2025-05-100
OAAI
Association of hepatitis B virus treatment with all-cause and liver-related mortality among individuals with HBV and cirrhosis: a population-based cohort study
2024-08-011
PRE
Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)

加拿大各种慢性乙型肝炎患者的临床结果和定量HBV表面抗原水平: 加拿大CHB的回顾性真实世界研究 (REVEAL-Canada)

2022-11-292
OAAI
Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogue

在核苷 (酸) ide类似物的465例患者中,乙型肝炎病毒学应答和肝硬度改善的全国回顾性研究

2022-08-214
OAAI
Ethnicity, disease severity, and survival in Canadian patients with primary biliary cholangitis
2022-03-1510
PRE